Home
Segments
SOLUTIONS
MYIOFLOXGENCOMPUTER VISIONDIGITAL ASSISTANT
Case studies
About
Career
LISTEN TO BEYOND AI PODCAST  ···   LISTEN TO BEYOND AI PODCAST  ···   
LISTEN TO BEYOND AI PODCAST  ···   LISTEN TO BEYOND AI PODCAST  ···   
Icon LinkedInIcon XIcon Medium
CONTACT
Home
Segments
SOLUTIONS
MYIOFLOXGENCOMPUTER VISIONDIGITAL ASSISTANT
Case studies
About
Career
LISTEN TO BEYOND AI PODCAST  ···   LISTEN TO BEYOND AI PODCAST  ···   
LISTEN TO BEYOND AI PODCAST  ···   LISTEN TO BEYOND AI PODCAST  ···   
Icon LinkedInIcon XIcon Medium
CONTACT
CASE STUDY

Population disease-spread modelling

SHARE-ERIC
SHARE-ERIC epidemiological modelling thumbnail

Client

SHARE-ERIC

Segment

Healthcare

Solutions

abmSHARE / epidemic simulation

Date

2026

↳

DNAi case study: Agent-based epidemic simulation on European SHARE survey data (abmSHARE, Covasim extension).

01 —

The Task

Context

SHARE-COVID19 is part of the SHARE-ERIC research infrastructure. The SHARE survey covers 140k+ respondents aged 50+ across 25+ European countries.

DNAi collaborated with economists at the Economics Institute of the Czech Academy of Sciences to build simulation software for infectious disease spread on top of those population datasets.

Challenge

Realistic modelling must fuse demographics, social contact structure, mobility, and public health data which differ widely in shape and quality.

02 —

The Reaction

Approach

DNAi delivered abmSHARE, extending the open-source Covasim agent-based model.

  • Ingest SHARE, Eurostat, and auxiliary public datasets
  • Regional geography (e.g. NUTS-2)
  • Scenario controls for interventions (lockdowns, testing, vaccination)
  • Configurable JSON / CSV-driven experiments for researchers

Technology

ABM with agents representing individuals, calibrated on observed COVID-19 dynamics, supporting counterfactual and policy simulations.

03 —

The Effect

Outcomes

A publicly available toolchain used by SHARE research teams to run realistic transmission scenarios and compare intervention mixes.

The model remains extensible beyond COVID-19 for other pathogens and health-policy analyses.

NEXT CASE
Zentiva portfolio analytics thumbnail
Manufacturing

Pharmaceutical portfolio optimisation

Zentiva
↩  VIEW ALL
-NECT
CON-

Keep in Touch
with Technological
Evolution

Curious how AI could enrich your industry DNA? Connect with us to meet our expertise.

I'm interested in...
You need to select at least one checkbox.
Thank you for sending your message!
Oops! Something went wrong while submitting the form.

DNAi

U Nikolajky 1097/3
150 00, Smíchov, Prague 5
Czech Republic

dnai@dnai.ai
+420 721 201 219

marketing@dnai.ai

Icon LinkedInIcon XIcon Medium

Navigation

Home
Segments
Case Studies
About
Career
Contact

Beyond AI Podcast ↗
Media Kit ↗

Newsletter

Sign up to stay on top of our latest AI research and newest products.

Thank you for signing up!
Oops! Something went wrong. TRY AGAIN.
COPYRIGHT © 2023, DNAI.AI
↑ BACK TO TOP
Your browser does not support the video tag.